Fairness in cost-benefit analysis: A methodology for health technology assessment

Anne-Laure Samson, Erik Schokkaert, Clémence Thebaut (), Brigitte Dormont, Marc Fleurbaey, Stéphane Luchini () and Karine van de Voorde
Additional contact information
Clémence Thebaut: LEDa - Laboratoire d'Economie de Dauphine - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres, OMIJ - Observatoire des Mutations Institutionnelles et Juridiques - GIO - Gouvernance des Institutions et des Organisations - UNILIM - Université de Limoges, HAS - Haute Autorité de Santé [Saint-Denis La Plaine]
Stéphane Luchini: AMSE - Aix-Marseille Sciences Economiques - EHESS - École des hautes études en sciences sociales - AMU - Aix Marseille Université - ECM - École Centrale de Marseille - CNRS - Centre National de la Recherche Scientifique
Karine van de Voorde: KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven

Post-Print from HAL

Abstract: We evaluate the introduction of various forms of antihypertensive treatments in France with a distribution-sensitive cost-benefit analysis. Compared to traditional cost-benefit analysis, we implement distributional weighting based on equivalent incomes, a new concept of individual well-being that does respect individual preferences but is not subjectively welfarist. Individual preferences are estimated on the basis of a contingent valuation question, introduced into a representative survey of the French population. Compared to traditional cost-effectiveness analysis in health technology assessment, we show that it is feasible to go beyond a narrow evaluation of health outcomes while still fully exploiting the sophistication of medical information. Sensitivity analysis illustrates the relevancy of this richer welfare framework, the importance of the distinction between an ex ante and an ex post approach, and the need to consider distributional effects in a broader institutional setting.

Keywords: Antihypertensive treatment; cost-benefit analysis; distributional weights; equivalent income (search for similar items in EconPapers)
Date: 2018-01
References: Add references at CitEc
Citations: View citations in EconPapers (11)

Published in Health Economics, 2018, 27 (1), pp.102 - 114. ⟨10.1002/hec.3515⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Journal Article: Fairness in cost‐benefit analysis: A methodology for health technology assessment (2018)
Working Paper: Fairness in cost-benefit analysis: A methodology for health technology assessment (2018)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02302587

DOI: 10.1002/hec.3515

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().